Your browser doesn't support javascript.
loading
Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
Rousel, Jannik; Bergmans, Menthe E; van der Meulen, Laura W J; Pagan, Lisa; de Bruin, Digna T; de Kam, Marieke L; Klarenbeek, Naomi B; Bouwstra, Joke A; Seyger, Marieke M B; van den Reek, Juul M P A; Niemeyer-van der Kolk, Tessa; Rissmann, Robert; van Doorn, Martijn B A.
Afiliação
  • Rousel J; Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Bergmans ME; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.
  • van der Meulen LWJ; Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Pagan L; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.
  • de Bruin DT; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.
  • de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands.
  • Klarenbeek NB; Centre for Human Drug Research, Leiden, The Netherlands.
  • Bouwstra JA; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.
  • Seyger MMB; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Niemeyer-van der Kolk T; Centre for Human Drug Research, Leiden, The Netherlands.
  • Rissmann R; Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands. Electronic address: rrissmann@chdr.nl.
  • van Doorn MBA; Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
J Am Acad Dermatol ; 90(2): 395-397, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37804933
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Quimioterapia de Indução Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Quimioterapia de Indução Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Holanda